Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study C Russell, F Ali, F Nafeh, J Rehm, S LeBlanc, T Elton-Marshall Journal of substance abuse treatment 129, 108374, 2021 | 104 | 2021 |
Post-overdose interventions triggered by calling 911: Centering the perspectives of people who use drugs (PWUDs) KD Wagner, RW Harding, R Kelley, B Labus, SR Verdugo, E Copulsky, ... PloS one 14 (10), e0223823, 2019 | 79 | 2019 |
Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications JM Bowles, K McDonald, N Maghsoudi, H Thompson, C Stefan, ... Harm reduction journal 18, 1-6, 2021 | 52 | 2021 |
“I Gotta Go With Modern Technology, So I’m Gonna Give’em the Narcan”: the diffusion of innovations and an opioid overdose prevention program JM Bowles, SE Lankenau Qualitative health research 29 (3), 345-356, 2019 | 33 | 2019 |
Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips MK Reed, NS Imperato, JM Bowles, VJ Salcedo, A Guth, KL Rising Drug and alcohol dependence reports 4, 100074, 2022 | 29 | 2022 |
“Generally, you get 86′ ed because you're a liability”: An application of Integrated Threat Theory to frequently witnessed overdoses and social distancing responses JM Bowles, LR Smith, SR Verdugo, KD Wagner, PJ Davidson Social Science & Medicine 260, 113190, 2020 | 26 | 2020 |
Overdose prevention and housing: a qualitative study examining drug use, overdose risk, and access to safer supply in permanent supportive housing in Vancouver, Canada A Ivsins, L MacKinnon, JM Bowles, A Slaunwhite, G Bardwell Journal of urban health 99 (5), 855-864, 2022 | 24 | 2022 |
Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada N Maghsoudi, J Bowles, D Werb Canadian Journal of Public Health 111 (4), 606-609, 2020 | 23 | 2020 |
Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities TL Gaines, KD Wagner, ML Mittal, JM Bowles, E Copulsky, M Faul, ... Drug and alcohol dependence 213, 108084, 2020 | 17 | 2020 |
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis M Karamouzian, B Rafat, G Kolla, K Urbanoski, K Atkinson, G Bardwell, ... International Journal of Drug Policy 120, 104157, 2023 | 11 | 2023 |
“I wanted to close the chapter completely… and I feel like that [carrying naloxone] would keep it open a little bit”: Refusal to carry naloxone among newly-abstinent opioid … JM Bowles, LR Smith, ML Mittal, RW Harding, E Copulsky, G Hennessy, ... International Journal of Drug Policy 94, 103200, 2021 | 11 | 2021 |
Factors associated with calling 911 for an overdose: an ethnographic decision tree modeling approach KD Wagner, B Koch, JM Bowles, SR Verdugo, RW Harding, PJ Davidson American journal of public health 111 (7), 1281-1283, 2021 | 11 | 2021 |
“We’re already doing this work”: ethical research with community-based organizations R Fielding-Miller, S Kim, J Bowles, S Streuli, P Davidson BMC medical research methodology 22 (1), 237, 2022 | 9 | 2022 |
Drug checking use and interest among people who inject drugs in Toronto, Canada I Rammohan, Z Bouck, S Fusigboye, J Bowles, K McDonald, ... International Journal of Drug Policy 107, 103781, 2022 | 9 | 2022 |
Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City AS Bennett, J Scheidell, JM Bowles, M Khan, A Roth, L Hoff, C Marini, ... Harm reduction journal 19 (1), 20, 2022 | 8 | 2022 |
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study G Bardwell, JM Bowles, M Mansoor, D Werb, T Kerr Substance abuse treatment, prevention, and policy 18 (1), 14, 2023 | 6 | 2023 |
Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada KM Scarfone, N Maghsoudi, K McDonald, H Thompson, C Stefan, ... Clinical Toxicology 60 (8), 979-984, 2022 | 4 | 2022 |
Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico JM Bowles, S Jain, X Sun, SA Strathdee, K DeBeck, MJ Milloy, Z Bouck, ... International Journal of Drug Policy 95, 103398, 2021 | 4 | 2021 |
Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs JM Bowles, EC Copulsky, MK Reed International Journal of Drug Policy 125, 104338, 2024 | 3 | 2024 |
Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic JM Bowles, G Kolla, LR Smith, A Scheim, Z Dodd, D Werb Drug and Alcohol Dependence Reports 7, 100167, 2023 | 3 | 2023 |